Nudibranchs as Sources of Marine Natural Products with Antitumor Activity: A Comprehensive Review
Marine Drugs · 03.08.2025 · 23 (8) · 319
DOI: 10.3390/md23080319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 03.08.2025. Verfasst von Máximo Servillera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain. Hauptthemen laut MEDLINE: Antineoplastic Agents, Biological Products, Gastropoda, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nudibranchs have garnered increasing interest in biomedical research due to their complex chemical defense mechanisms, many of which are derived from their diet, including sponges, cnidarians, tunicates, and algae. Their remarkable ability to sequester dietary toxins and synthesize secondary metabolites positions them as a promising source of biologically active compounds with potential therapeutic applications, particularly in oncology. This study aimed to review and summarize the available literature on the bioactive potential of nudibranch-derived compounds, focusing mainly on their antitumor properties. Although research in this area is still limited, recent studies have identified alkaloids and terpenoids isolated from species such as Dolabella auricularia, Jorunna funebris, Dendrodoris fumata, and members of the genus Phyllidia. These compounds exhibit notable cytotoxic activity against human cancer cell lines, including those from colon (HCT-116, HT-29, SW-480), lung (A549), and breast (MCF7) cancer. These findings suggest that compounds derived from nudibranchs could serve as scaffolds for the development of more effective and selective anticancer therapies. In conclusion, nudibranchs represent a valuable yet underexplored resource for antitumor drug discovery, with significant potential to contribute to the development of novel cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain.
- Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, 18012 Granada, Spain.
- Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, 18071 Granada, Spain.
- Aula del Mar CEI·Mar, Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
ORCID-Profile: Máximo Servillera, Mercedes Peña, Héctor J Pula, Jose Prados, Consolación Melguizo
Zitieren
APA
Servillera, M., Peña, M., Cabeza, L., Pula, H. J., Prados, J., & Melguizo, C. (2025). Nudibranchs as Sources of Marine Natural Products with Antitumor Activity: A Comprehensive Review. Marine Drugs, 23(8), 319. https://doi.org/10.3390/md23080319
Vancouver
Servillera M, Peña M, Cabeza L, Pula HJ, Prados J, Melguizo C. Nudibranchs as Sources of Marine Natural Products with Antitumor Activity: A Comprehensive Review. Marine Drugs. 2025;23(8):319. doi:10.3390/md23080319
BibTeX
@article{Servillera2025,
author = {Servillera, Máximo and Peña, Mercedes and Cabeza, Laura and Pula, Héctor J and Prados, Jose and Melguizo, Consolación},
title = {Nudibranchs as Sources of Marine Natural Products with Antitumor Activity: A Comprehensive Review},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {8},
pages = {319},
doi = {10.3390/md23080319}
}
EUVIMED